{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T08:52:07Z","timestamp":1762159927809},"reference-count":54,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2003,1,1]],"date-time":"2003-01-01T00:00:00Z","timestamp":1041379200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2003,1]]},"DOI":"10.1006\/exnr.2002.8044","type":"journal-article","created":{"date-parts":[[2002,12,30]],"date-time":"2002-12-30T13:11:55Z","timestamp":1041253915000},"page":"47-59","source":"Crossref","is-referenced-by-count":39,"title":["Mitochondrial Complex Inhibitors Preferentially Damage Substantia Nigra Dopamine Neurons in Rat Brain Slices"],"prefix":"10.1006","volume":"179","author":[{"given":"Petra T.","family":"Bywood","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen M.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1006\/exnr.2002.8044_RF1","first-page":"148","article-title":"Are dopaminergic neurons selectively vulnerable to Parkinson's disease?","volume":"60","author":"Agid","year":"1993","journal-title":"Adv. Neurol."},{"key":"10.1006\/exnr.2002.8044_RF2","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/ana.410310202","article-title":"Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?","volume":"31","author":"Beal","year":"1992","journal-title":"Ann. Neurol."},{"key":"10.1006\/exnr.2002.8044_RF3","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/81834","article-title":"Chronic systemic pesticide exposure reproduces features of Parkinson's disease","volume":"3","author":"Betarbet","year":"2000","journal-title":"Nat. Neurosci."},{"key":"10.1006\/exnr.2002.8044_RF4","doi-asserted-by":"crossref","first-page":"7105","DOI":"10.1073\/pnas.92.15.7105","article-title":"Chronic mitochondrial energy impairment produces selective striatal degeneration and abnormal choreiform movements in primates","volume":"92","author":"Brouillet","year":"1995","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/exnr.2002.8044_RF5","doi-asserted-by":"crossref","first-page":"4546","DOI":"10.1073\/pnas.80.14.4546","article-title":"A primate model of parkinsonism: Selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine","volume":"80","author":"Burns","year":"1983","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1006\/exnr.2002.8044_RF6","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1006\/exnr.1999.7259","article-title":"Dendrite loss is a characteristic early indicator of toxin-induced neurodegeneration in rat midbrain slices","volume":"161","author":"Bywood","year":"2000","journal-title":"Exp. Neurol."},{"key":"10.1006\/exnr.2002.8044_RF7","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1006\/exnr.2000.7310","article-title":"Differential vulnerabilities of substantia nigra catecholamine neurons to excitatory amino acid-induced degeneration in rat midbrain slices","volume":"162","author":"Bywood","year":"2000","journal-title":"Exp. Neurol."},{"key":"10.1006\/exnr.2002.8044_RF8","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0304-3940(99)00990-8","article-title":"Loss of tyrosine hydroxylase immunoreactivity in dendrites is a sensitive index of kainic acid-induced damage in rat substantia nigra neurons in vivo","volume":"280","author":"Bywood","year":"2000","journal-title":"Neurosci. Lett."},{"key":"10.1006\/exnr.2002.8044_RF9","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/BF03033207","article-title":"Catecholamine neuron groups in rat brain slices differ in their susceptibility to excitatory amino acid induced dendritic degeneration","volume":"3","author":"Bywood","year":"2001","journal-title":"Neurotoxicol. Res."},{"key":"10.1006\/exnr.2002.8044_RF10","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/0166-2236(88)90200-7","article-title":"Calcium-mediated neurotoxicity: Relationship to specific channel types and role in ischemic damage","volume":"11","author":"Choi","year":"1988","journal-title":"Trends Neurosci."},{"key":"10.1006\/exnr.2002.8044_RF11","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1017\/S0033291700049588","article-title":"The aftermath of boxing","volume":"3","author":"Corsellis","year":"1973","journal-title":"Psychol. Med."},{"key":"10.1006\/exnr.2002.8044_RF12","doi-asserted-by":"crossref","first-page":"12753","DOI":"10.1074\/jbc.273.21.12753","article-title":"Energy thresholds in brain mitochondria: Potential involvement in neurodegeneration","volume":"273","author":"Davey","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1006\/exnr.2002.8044_RF13","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/j.1471-4159.1990.tb04160.x","article-title":"N-Methyl-D-aspartate receptor activation and Ca2+ account for poor pyramidal cell structure in hippocampal slices","volume":"55","author":"Feig","year":"1990","journal-title":"J. Neurochem."},{"key":"10.1006\/exnr.2002.8044_RF14","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1111\/j.1471-4159.1993.tb13431.x","article-title":"The N-methyl-D-aspartate antagonist MK-801 fails to protect dopaminergic neurons from 1-methyl-4-phenylpyridinium toxicity in vitro","volume":"60","author":"Finiels-Marlier","year":"1993","journal-title":"J. Neurochem."},{"key":"10.1006\/exnr.2002.8044_RF15","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1046\/j.1471-4159.1998.70010268.x","article-title":"Increased protein oxidation in human substantia nigra pars compacta in comparison with basal ganglia and prefrontal cortex measured with an improved dinitrophenylhydrazine assay","volume":"70","author":"Floor","year":"1998","journal-title":"J. Neurochem."},{"key":"10.1006\/exnr.2002.8044_RF16","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1749-6632.1992.tb24523.x","article-title":"Midbrain dopaminergic cell loss in Parkinson's disease and MPTP-induced parkinsonism: Sparing of calbindin-D28k-containing cells","volume":"648","author":"German","year":"1992","journal-title":"Ann. NY Acad. Sci."},{"key":"10.1006\/exnr.2002.8044_RF17","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1006\/neur.1996.0041","article-title":"The neurotoxin MPTP causes degeneration of specific nucleus A8, A9 and A10 dopaminergic neurons in the mouse","volume":"5","author":"German","year":"1996","journal-title":"Neurodegeneration"},{"key":"10.1006\/exnr.2002.8044_RF18","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1212\/WNL.50.5.1346","article-title":"The risk of Parkinson's disease with exposure to pesticides, farming, well water, and rural living","volume":"50","author":"Gorell","year":"1998","journal-title":"Neurology"},{"key":"10.1006\/exnr.2002.8044_RF19","first-page":"292","article-title":"Immunohistochemical studies on complexes I, II, III, and IV of mitochondria in Parkinson's disease","volume":"60","author":"Hattori","year":"1993","journal-title":"Adv. Neurol."},{"key":"10.1006\/exnr.2002.8044_RF20","first-page":"S173","article-title":"Neurotransmitter-mediated mechanisms of traumatic brain injury: Acetylcholine and excitatory amino acids","volume":"9","author":"Hayes","year":"1992","journal-title":"J. Neurotrauma"},{"key":"10.1006\/exnr.2002.8044_RF21","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0304-3940(85)90580-4","article-title":"Dopaminergic toxicity of rotenone and the 1-methyl-4-phenylpyridinium ion after their stereotaxic administration to rats: implication for the mechanism of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine toxicity","volume":"62","author":"Heikkila","year":"1985","journal-title":"Neurosci. Lett."},{"key":"10.1006\/exnr.2002.8044_RF22","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1615\/CritRevNeurobiol.v10.i2.50","article-title":"Neurodegenerative disorders: Clues from glutamate and energy metabolism","volume":"10","author":"Ikonomidou","year":"1996","journal-title":"Crit. Rev. Neurobiol."},{"key":"10.1006\/exnr.2002.8044_RF23","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1006\/exnr.1998.6782","article-title":"Degeneration of the dendritic arbor as an index of neurotoxicity in identified catecholamine neurons in rat brain slices","volume":"151","author":"Johnson","year":"1998","journal-title":"Exp. Neurol."},{"key":"10.1006\/exnr.2002.8044_RF24","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1006\/exnr.1998.6783","article-title":"Excitatory amino acid-induced degeneration of dendrites of catecholamine neurons in rat substantia nigra","volume":"151","author":"Johnson","year":"1998","journal-title":"Exp. Neurol."},{"key":"10.1006\/exnr.2002.8044_RF25","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1006\/exnr.1997.6578","article-title":"Neurotoxic effects of kainic acid on substantia nigra neurons in rat brain slices","volume":"146","author":"Johnson","year":"1997","journal-title":"Exp. Neurol."},{"key":"10.1006\/exnr.2002.8044_RF26","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0165-0270(95)00114-X","article-title":"Anatomical and immunohistochemical identification of catecholaminergic neurones in brain slice preparations used in electrophysiology","volume":"64","author":"Johnson","year":"1996","journal-title":"J. Neurosci. Methods"},{"key":"10.1006\/exnr.2002.8044_RF27","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0079-6123(08)64576-8","article-title":"The hypothalamic lateral tuberal nucleus: Normal anatomy and changes in neurological diseases","volume":"93","author":"Kremer","year":"1992","journal-title":"Prog. Brain Res."},{"key":"10.1006\/exnr.2002.8044_RF28","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1126\/science.6823561","article-title":"Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis","volume":"219","author":"Langston","year":"1983","journal-title":"Science"},{"key":"10.1006\/exnr.2002.8044_RF29","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S0753-3322(99)80077-8","article-title":"Pesticides and Parkinson's disease","volume":"53","author":"Le Couteur","year":"1999","journal-title":"Biomed. Pharmacother."},{"key":"10.1006\/exnr.2002.8044_RF30","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/brain\/115.2.333","article-title":"Brain, skeletal muscle and platelet homogenate mitochondrial function in Parkinson's disease","volume":"115","author":"Mann","year":"1992","journal-title":"Brain"},{"key":"10.1006\/exnr.2002.8044_RF31","doi-asserted-by":"crossref","first-page":"5912","DOI":"10.1523\/JNEUROSCI.15-09-05912.1995","article-title":"A selective toxicity toward cultured mesencephalic dopaminergic neurons is induced by the synergistic effects of energetic metabolism impairment and NMDA receptor activation","volume":"15","author":"Marey-Semper","year":"1995","journal-title":"J. Neurosci."},{"key":"10.1006\/exnr.2002.8044_RF32","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1600-0404.1991.tb05016.x","article-title":"Progression and survival in Parkinson's disease","volume":"136","author":"Marttila","year":"1991","journal-title":"Acta Neurol. Scand. Suppl."},{"key":"10.1006\/exnr.2002.8044_RF33","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1002\/ana.410180507","article-title":"Preservation of hypothalamic dopaminergic neurons in Parkinson's disease","volume":"18","author":"Matzuk","year":"1985","journal-title":"Ann. Neurol."},{"key":"10.1006\/exnr.2002.8044_RF34","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/j.1600-0773.1990.tb00773.x","article-title":"The neurotoxicity of MPTP and the relevance to Parkinson's disease","volume":"67","author":"McCrodden","year":"1990","journal-title":"Pharmacol. Toxicol."},{"key":"10.1006\/exnr.2002.8044_RF35","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/0165-6147(90)90184-A","article-title":"Excitatory amino acid neurotoxicity and neurodegenerative disease","volume":"11","author":"Meldrum","year":"1990","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1006\/exnr.2002.8044_RF36","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1146\/annurev.ne.01.030178.001021","article-title":"Central catecholamine neuron systems: Anatomy and physiology of the dopamine systems","volume":"1","author":"Moore","year":"1978","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1006\/exnr.2002.8044_RF37","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0006-8993(88)90765-2","article-title":"Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced","volume":"451","author":"Novelli","year":"1988","journal-title":"Brain Res."},{"key":"10.1006\/exnr.2002.8044_RF38","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/ana.410260606","article-title":"Abnormalities of the electron transport chain in idiopathic Parkinson's disease","volume":"26","author":"Parker","year":"1989","journal-title":"Ann. Neurol."},{"key":"10.1006\/exnr.2002.8044_RF39","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S0166-2236(97)01100-4","article-title":"The GluR2 (GluR-B) hypothesis: Ca(2+)-permeable AMPA receptors in neurological disorders","volume":"20","author":"Pellegrini-Giampietro","year":"1997","journal-title":"Trends Neurosci."},{"key":"10.1006\/exnr.2002.8044_RF40","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1152\/jn.1994.71.4.1591","article-title":"Ascorbic acid, but not glutathione, is taken up by brain slices and preserves cell morphology","volume":"71","author":"Rice","year":"1994","journal-title":"J. Neurophysiol."},{"key":"10.1006\/exnr.2002.8044_RF41","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/0006-8993(92)91371-K","article-title":"Inhibition of energy metabolism by 3-nitropropionic acid activates ATP-sensitive potassium channels","volume":"586","author":"Riepe","year":"1992","journal-title":"Brain Res."},{"key":"10.1006\/exnr.2002.8044_RF42","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/0306-4522(92)90525-7","article-title":"Calretinin and calbindin-D28k in rat brain: Patterns of partial co-localization","volume":"51","author":"Rogers","year":"1992","journal-title":"Neuroscience"},{"key":"10.1006\/exnr.2002.8044_RF43","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1002\/ana.410190202","article-title":"Glutamate and the pathophysiology of hypoxic\u2013ischemic brain damage","volume":"19","author":"Rothman","year":"1986","journal-title":"Ann. Neurol."},{"key":"10.1006\/exnr.2002.8044_RF44","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJM199205283262204","article-title":"Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis","volume":"326","author":"Rothstein","year":"1992","journal-title":"N. Engl. J. Med."},{"key":"10.1006\/exnr.2002.8044_RF45","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1111\/j.1471-4159.1990.tb02325.x","article-title":"Mitochondrial complex I deficiency in Parkinson's disease","volume":"54","author":"Schapira","year":"1990","journal-title":"J. Neurochem."},{"key":"10.1006\/exnr.2002.8044_RF46","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1749-6632.1999.tb07818.x","article-title":"The alpha-ketoglutarate dehydrogenase complex","volume":"893","author":"Sheu","year":"1999","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1006\/exnr.2002.8044_RF47","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1097\/00003246-198810000-00006","article-title":"Mechanisms of ischemic brain damage","volume":"16","author":"Siesjo","year":"1988","journal-title":"Crit. Care Med."},{"key":"10.1006\/exnr.2002.8044_RF48","doi-asserted-by":"crossref","first-page":"1979","DOI":"10.1111\/j.1471-4159.1992.tb10081.x","article-title":"MK-801 fails to protect against the dopaminergic neuropathology produced by systemic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice or intranigral 1-methyl-4-phenylpyridinium in rats","volume":"58","author":"Sonsalla","year":"1992","journal-title":"J. Neurochem."},{"key":"10.1006\/exnr.2002.8044_RF49","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0006-8993(00)02348-9","article-title":"On the altered expression of tyrosine hydroxylase and calbindin-D 28kD immunoreactivities and viability of neurons in the ventral tegmental area of Tsai following injections of 6-hydroxydopamine in the medial forebrain bundle in the rat","volume":"869","author":"Tan","year":"2000","journal-title":"Brain Res."},{"key":"10.1006\/exnr.2002.8044_RF50","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/S0165-6147(98)01230-9","article-title":"Glutamate transporters are oxidant-vulnerable: A molecular link between oxidative and excitotoxic neurodegeneration?","volume":"19","author":"Trotti","year":"1998","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1006\/exnr.2002.8044_RF51","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/349414a0","article-title":"Protection of substantia nigra from MPP+ neurotoxicity by N-methyl-D-aspartate antagonists","volume":"349","author":"Turski","year":"1991","journal-title":"Nature"},{"key":"10.1006\/exnr.2002.8044_RF52","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1046\/j.1471-4159.1997.68010426.x","article-title":"Energy stress-induced dopamine loss in glutathione peroxidase-overexpressing transgenic mice and in glutathione-depleted mesencephalic cultures","volume":"68","author":"Zeevalk","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1006\/exnr.2002.8044_RF53","first-page":"1285","article-title":"Chemically induced hypoglycemia and anoxia: Relationship to glutamate receptor-mediated toxicity in retina","volume":"253","author":"Zeevalk","year":"1990","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1006\/exnr.2002.8044_RF54","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/j.1471-4159.1992.tb09429.x","article-title":"MK-801 prevents 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in primates","volume":"59","author":"Zuddas","year":"1992","journal-title":"J. Neurochem."}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488602980441?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488602980441?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,11]],"date-time":"2020-03-11T22:22:24Z","timestamp":1583965344000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488602980441"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,1]]},"references-count":54,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2003,1]]}},"alternative-id":["S0014488602980441"],"URL":"https:\/\/doi.org\/10.1006\/exnr.2002.8044","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2003,1]]}}}